Thrombin antithrombin complex and IL-18 serum levels in stroke patients

Neurology International

Volumn 2, Issue 1, 2010, Pages 1-6

  Piazza, Ornella ^a   Scarpati, Giuliana ^a   Cotena, Simona ^a   Lonardo, Maria ^a   Tufano, Rosalba ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ATIII; IL 18; S100B; Stroke

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN DEGRADATION PRODUCT; INTERLEUKIN 18; PROTEIN S100B; THROMBIN ANTITHROMBIN COMPLEX;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMATOSE PATIENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFLAMMATION; MALE; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; STROKE PATIENT;

EID: 77953384424     PISSN: 20358385     EISSN: 20358377     Source Type: Journal    
DOI: 10.4081/ni.2010.e1     Document Type: Article

References (61)

1. Vila N, Reverter JC, Yagüe J, Chamorro A. Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res 2000;20:325-9
2. Kataoka S, Hirose G, Hori A, et al. Activation of thrombosis and fibrinolysis following brain infarction. J Neurol Sci 2000;181:82-8.
3. Ince B, Bayram C, Harmanci H, Ulutin T. Hemostatic markers in ischemic stroke of undetermined etiology. Thromb Res 1999;96:169-74.
4. Haapaniemi E, Soinne L, Syrjala M. Serial changes in fibrinolysis and coagulation acivation markers in acute and convalescent phase of ischemic stroke. Act Neurol Scand 2004;110:242-7.
5. Ilzecka J, Stelmasiak Z, Dobosz B. Thrombogenesis in patients with ischemic stroke. Neurol Neurochir Pol 2001;35:793-801
6. Haapaniemi E, Tatlisumak T, Soinne L, et al. Natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke. Acta Neurol Scand 2002;105:107-14.
7. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002;61:1013-21.
8. Marsh BJ, Williams-Karnesky, StenzelPoore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009;158:1007-20.
9. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 2004;201:197-207.
10. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005;175:4320-30.
11. Bsibsi M, Persoon-Deen C, Verwer RW, et al. Toll-like receptor 3 on adult human astrocytes triggers production of neuro-protective mediators. Glia 2006;53:688-95.
12. Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Intervent 2003;3:466-77.
13. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
14. Kinouchi H, Sharp FR, Hill MP, et al. Induction of 70-kDa heat shock protein and hsp70 mRNA following transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1993;13:105-15.
15. Faraco G, Fossati S, Bianchi ME, et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurode-generation in vitro and in vivo. J Neurochem 2007;103:590-603.
16. Lehnardt S, Schott E, Trimbuch T, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 2008;28:2320-31.
17. Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-704.
18. Kataoka S, Hirose G, Hori A, et al. Activation of thrombosis and fibrinolysis following brain infarction. J Neurol Sci 2000;181:82-8.
19. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 1998;89:991-6.
20. Xi G, Wagner KR, Keep RF. The role of blood clot formation on early edema development following experimental intracerebral hemorrhage. Stroke 1998;29:2580-6.
21. Lee KR, Colon GP, Betz AL, et al. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996;84:91-6.
22. Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, bloodbrain barrier permeability, and cell survival in a rat model. J Neurosurg 1997;86: 272-8.
23. Lee KR, Betz AL, Keep RF, et al. Intracerebral infusion of thrombin as a cause of brain edema. J Neurosurg 1995;83:1045-50.
24. Lee KR, Betz AL, Kim S, et al. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neuochir 1996;138:396-400.
25. Lee KR, Drury I, Vitarbo E, Hoff JT. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg 1997;87:73-8.
26. Nishino A, Suzuki M, Othani H. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993;10:167-79.
27. O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999;285:1926-8.
28. Okajima K. Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation. Blood Coagul Fibrinolysis 1998;9:S25-S37.
29. Harada N, Okajima K, Kishimoto S, et al. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999; 93:157-64.
30. Ostrovsky L, Woodman RC, Payne D, et al. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997;96:2302-10.
31. Minnema MC, Chang AC, Jansen PM, et al. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood 2000; 95:1117-23.
32. Dickneite G, Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol 1999;19: 1566-72.
33. Inthorn D, Hoffmann JN, Hartl WH, et al. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock 1998;10:90-6.
34. Carrell RW. How serpins are shaping up. Science 1999;285:1861-63.
35. Vu TH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-68.
36. Zimmerman BJ, Paulson JC, Arrhenius TS, et al. Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: roles of P-selectin and sialyl Lewis X. Am J Physiol 1994;267:H1049-H1053.
37. Toothill VJ, Van-Mourik JA, Niewenhuis HK, et al. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol. 1990;145:283-91.
38. Klepfish A, Greco MA, Karpatkin S. Thrombin stimulates melanoma tumorcell binding to endothelial cells and subendothelial matrix. Int J Cancer. 1993;53:978-82.
39. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, et al. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993;54:793-806.
40. Eugene CB. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
41. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6.
42. Cuomo O, Pignataro G, Gala R, et al. Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and permanent focal ischemia. Stroke 2007; 38:3272-9.
43. Fisher M, Meiselman HJ. Hemorheological factors in cerebral ischemia. Stroke 1991;22:1164-9.
44. Tohgi H, Kawashima M, Tamura K, Suzuki H. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990; 21:1663-7.
45. Altes A, Abellan MT, Mateo J, et al. Hemostatic disturbances in acute ischemic stroke: A study of 86 patients. Acta Haematol 1995;94:10-5
46. Fon EA, Mackey A, Cote R, et al. Hemostatic marker in acute transient ischemic attacks. Stroke 1994;25:282-6.
47. Francis CW, Doughney K, Brenner B, et al. Increased immunoreactivity of plasma after fibrinolytic activation in anti-DD ELISA system. Circulation 1989;79:666-73.
48. Marder VJ. What does the "dimertest" test? Circulation 1990;82:1514-5.
49. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, et al. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 2005; 28:487-93.
50. Zaremba J, Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 2003;24:117-24.
51. Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104: 1598-603.
52. Yuen CM, Chiu CA, Chang LT, et al. Level and value of interleukin-18 after acute ischemic stroke. Circ J 2007;71:1691-6.
53. Kleindienst A, Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006;23:1185-200.
54. Jackson RG, Samra GS, Radcliffe J, et al. The early fall in levels of S-100 beta in traumatic brain injury. Clin Chem Lab Med 2000;38:1165-7.
55. Piazza O, Cotena S, Esposito G, et al. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir 2005;60:477-80.
56. Piazza O, Russo E, Cotena S, et al. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 2007;99:518-21.
57. Cotena S, Piazza O, Storti M. The S100B protein and traumatic brain injury. J Neurosurg 2006;104:435-6.
58. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ. Hemostatic markers in acute stroke. Stroke 1989;20:592-7.
59. Jauch EC, Lindsell C, Broderick J, et al. NINDS rt-PA Stroke Study Group. Association of serial biochemical markers with acute ischemic stroke. Stroke 2006;37:2508-13.
60. Kögel D, Peters M, König HG, et al. S100B potently activates p65fc-Rel transcriptional complex in hippocampal neurone: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 2004;127:913-20.
61. Piazza O, Russo E, Cotena S, et al. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 2007;99:518-21.